A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Trial Profile

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 18 Oct 2018

At a glance

  • Drugs Hepatitis B vaccine (Primary) ; ADVAX; Hepatitis B vaccine recombinant
  • Indications Hepatitis B
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms HBV003
  • Sponsors Vaxine
  • Most Recent Events

    • 10 Oct 2018 Planned initiation date changed from 1 Jun 2018 to 1 Dec 2018.
    • 04 May 2018 Planned End Date changed from 1 Mar 2019 to 1 Dec 2020.
    • 04 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top